Vitamin B combination reduces fluconazole toxicity in Wistar rats
- PMID: 30903555
- PMCID: PMC6593129
- DOI: 10.1007/s40199-019-00252-9
Vitamin B combination reduces fluconazole toxicity in Wistar rats
Abstract
Background: The major adverse effect associated with systemic administration of Fluconazole (FLZ), is hepatic toxicity. FLZ is most commonly used antifungal drug in treatment of invasive fungal infections.
Methods: FLZ toxicity was challenged by individual and in combination of three vitamins (B1, B2 B3). Animals were divided nine groups with six animals in each group. FLZ, at a dose of 50 mg/kg b.w, was orally administered for 90 days in experimental animals. Vitamins as individual or in combination was administered concomitantly to challenge or alleviate the toxicity of FLZ. They were sacrificed at the end of protocol for biochemical and histopathology analysis. Focus was made to observe the role of these micro nutrient's (vitamins) on liver for alteration in of pathological and physiological effects by FLZ in the Wistar albino rats.
Results: Combination of vitamin B1 + B2 + B3 in FLZ induced toxicity was able to restore the level of alkaline phosphatase (ALP) near to normal but with high level of ALP in B1 Control group. Aspartate aminotransferase (AST) was restored to normal in FLZ + B1, FLZ + B2 and FLZ + B1 + B2 + B3 groups and vice versa in FLZ + B3 group animals. Further the level of alanine aminotransferase (ALT) was restored to normal in FLZ + B3 animals. There were no significant changes found in total bilirubin (TBI), and direct bilirubin (DBI) as compare to normal control. Histopathological studies on animals' studies validated the serological results in normalizing the cellular architecture of liver.
Conclusions: Restoration of altered biochemical parameters and cellular architecture of hepatocytes by different combination of these vitamins proves the chemo preventive potential of these micro nutrients' in FLZ toxicity. Graphical abstract Vitamin B combination attenuates fluconazole toxicity.
Keywords: Fluconazole; Niacin; Riboflavin; Thiamine; Toxicity.
Conflict of interest statement
The Authors declare that there is no conflict of interest.
Figures


Similar articles
-
Potential effects of the combination of nicotinamide, vitamin B2 and vitamin C on oxidative-mediated hepatotoxicity induced by thioacetamide.Lipids Health Dis. 2018 Feb 14;17(1):29. doi: 10.1186/s12944-018-0674-z. Lipids Health Dis. 2018. PMID: 29444683 Free PMC article.
-
Carbon tetrachloride-induced hepatotoxicity in rat is reversed by treatment with riboflavin.Int Immunopharmacol. 2014 Aug;21(2):383-8. doi: 10.1016/j.intimp.2014.05.014. Epub 2014 May 27. Int Immunopharmacol. 2014. PMID: 24874442
-
Antioxidant and hepatoprotective activity of Fagonia schweinfurthii (Hadidi) Hadidi extract in carbon tetrachloride induced hepatotoxicity in HepG2 cell line and rats.J Ethnopharmacol. 2013 Dec 12;150(3):973-81. doi: 10.1016/j.jep.2013.09.048. Epub 2013 Oct 17. J Ethnopharmacol. 2013. PMID: 24140589
-
Vitamins B1, B2, B3 and B9 - Occurrence, Biosynthesis Pathways and Functions in Human Nutrition.Mini Rev Med Chem. 2017;17(12):1075-1111. doi: 10.2174/1389557516666160725095729. Mini Rev Med Chem. 2017. PMID: 27457213 Review.
-
Biological Properties of Vitamins of the B-Complex, Part 1: Vitamins B1, B2, B3, and B5.Nutrients. 2022 Jan 22;14(3):484. doi: 10.3390/nu14030484. Nutrients. 2022. PMID: 35276844 Free PMC article. Review.
References
-
- O'Leary RA, Einav S, Leone M, Madách K, Martin C, Martin-Loeches I. Management of invasive candidiasis and candidaemia in critically ill adults: expert opinion of the European Society of Anaesthesia Intensive Care Scientific Subcommittee. J Hosp Infect. 2018;98(4):382–390. doi: 10.1016/j.jhin.2017.11.020. - DOI - PubMed
-
- Cho SY, Lee DG, Choi JK, Lee HJ, Kim SH, Park SH, Choi SM, Choi JH, Yoo JH, Kim YJ, Kim HJ, Min WS, Back H, Kang S, Lee EK. Cost-benefit analysis of Posaconazole versus FLZ or Itraconazole as a primary antifungal prophylaxis in high-risk hematologic patients: a propensity score-matched analysis. Clin Ther. 2015;37(9):2019–2027. doi: 10.1016/j.clinthera.2015.06.014. - DOI - PubMed
-
- Malhi V, Colburn D, Williams SJ, Hop CE, Dresser MJ, Chandra P, Graham RA. A clinical drug-drug interaction study to evaluate the effect of a proton-pump inhibitor, a combined P-glycoprotein/cytochrome 450 enzyme (CYP)3A4 inhibitor, and a CYP2C9 inhibitor on the pharmacokinetics of vismodegib. Cancer Chemother Pharmacol. 2016;78(1):41–49. doi: 10.1007/s00280-016-3020-z. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical